BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31915699)

  • 1. Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.
    Chen EB; Wei YC; Liu HN; Tang C; Liu ML; Peng K; Liu T
    Biomed Res Int; 2019; 2019():6710428. PubMed ID: 31915699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
    Liu X; Sheng W; Wang Y
    J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
    Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
    BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.
    He R; Yang Q; Dong X; Wang Y; Zhang W; Shen L; Zhang Z
    Oncotarget; 2017 Apr; 8(14):23817-23830. PubMed ID: 28423604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AFP-producing gastric cancer and hepatoid gastric cancer].
    Wang YK; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
    Zuo CT; Ju Q
    Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients.
    Wang D; Li C; Xu Y; Xing Y; Qu L; Guo Y; Zhang Y; Sun X; Suo J
    Int J Clin Exp Pathol; 2015; 8(6):6345-55. PubMed ID: 26261510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
    Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
    Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
    Wang YK; Shen L; Jiao X; Zhang XT
    World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
    Liu D; Li B; Yan B; Liu L; Jia Y; Wang Y; Ma X; Yang F
    Int J Clin Exp Pathol; 2020; 13(9):2439-2446. PubMed ID: 33042357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer.
    Hirajima S; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Ikoma H; Otsuji E
    World J Gastroenterol; 2013 Sep; 19(36):6055-61. PubMed ID: 24106406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
    Nagai E; Ueyama T; Yao T; Tsuneyoshi M
    Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
    Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China.
    Qu BG; Bi WM; Qu BT; Qu T; Han XH; Wang H; Liu YX; Jia YG
    Medicine (Baltimore); 2016 Apr; 95(15):e3399. PubMed ID: 27082614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
    Chen Y; Qu H; Jian M; Sun G; He Q
    Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic and immunohistochemical analyses of α-fetoprotein--producing cancer of the stomach.
    Kinjo T; Taniguchi H; Kushima R; Sekine S; Oda I; Saka M; Gotoda T; Kinjo F; Fujita J; Shimoda T
    Am J Surg Pathol; 2012 Jan; 36(1):56-65. PubMed ID: 22173117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
    Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
    J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.